Fig. 2From: Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53Purity, DNA content, and doubling time of ZJU-0327, ZJU-0725, and ZJU-1127 cell lines. a The purity was evaluated by flow cytometry and statistical analysis. b DNA content and cell cycle distribution of normal lymphocytes and MCF-7, ZJU-0327, ZJU-0725, and ZJU-1127 cells were evaluated by flow cytometry and statistical analysis. c Growth rate of ZJU-0327, ZJU-0725, and ZJU-1127 cells was determined with the CCK-8 assayBack to article page